4.2 Article

Positron Emission Tomography Imaging of Mu- and Delta-Opioid Receptor Binding in Alcohol-Dependent and Healthy Control Subjects

期刊

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
卷 35, 期 12, 页码 2162-2173

出版社

WILEY-BLACKWELL
DOI: 10.1111/j.1530-0277.2011.01565.x

关键词

Alcoholism; Abstinence; Brain Imaging; Carfentanil; Naltrindole

资金

  1. National Institute of Alcohol Abuse and Alcoholism (NIAAA) [R01AA11872, R01AA11855, R37AA12303]
  2. Kenneth Lattman Foundation
  3. Lilly Research Laboratories

向作者/读者索取更多资源

Background: The endogenous opioid system plays a significant role in alcohol dependence. The goal of the current study was to investigate regional brain mu-opioid receptor (MOR) and delta-opioid receptor (DOR) availability in recently abstinent alcohol-dependent and age-matched healthy control men and women with positron emission tomography (PET) imaging. Methods: Alcohol-dependent subjectsCompleted an inpatient protocol, which included medically supervised withdrawal and PET imaging on day 5 of abstinence.Control subjectsCompleted PET imaging following an overnight stay. PET scans with the MOR-selective ligand [C-11]Carfentanil (CFN) wereCompleted in 25 alcohol-dependent and 30Control subjects. Most of these same subjects (20 alcohol-dependent subjects and 18Controls) alsoCompleted PET scans with the DOR-selective ligand [C-11] methylnaltrindole (MeNTL). Results: Volumes of interest and statistical parametric mapping analyses indicated that alcohol- dependent subjects had significantly higher [C-11]CFN binding potential (BPND) than healthy controls in multiple brain regions including the ventral striatum when adjusting for age, gender, and smoking status. There was an inverse relationship between [C-11]CFN BPND andCraving in several brain regions in alcohol-dependent subjects. Groups did not differ in [C-11] MeNTL BPND; however, [C-11] MeNTL BPND inCaudate was positivelyCorrelated with recent alcohol drinking in alcohol-dependent subjects. Conclusions: Our observation of higher [C-11]CFN BPND in alcohol-dependent subjectsCan result from up-regulation of MOR and / or reduction in endogenous opioid peptides following long-term alcoholConsumption, dependence, and / or withdrawal. Alternatively, the higher [C-11]CFN BPND in alcohol-dependent subjects may be an etiological difference that predisposed these individuals to alcohol dependence or may have developed as a result of increased exposure toChildhood adversity, stress, and other environmental factors known to increase MOR. Although the direction of group differences in [C-11] MeNTL BPND was similar in many brain regions, differences did not achieve statistical significance, perhaps as a result of our limited sample size. Additional research is needed to furtherClarify these relationships. The finding that alcohol-dependent subjects had higher [C-11]CFN BPND isConsistent with a prominent role of the MOR in alcohol dependence.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia

Dean F. Wong, Hiroto Kuwabara, Andrew G. Horti, Joshua M. Roberts, Ayon Nandi, Nicola Cascella, James Brasic, Elise M. Weerts, Kelly Kitzmiller, Jenny A. Phan, Lorena Gapasin, Akira Sawa, Heather Valentine, Gary Wand, Chakradhar Mishra, Noble George, Michael McDonald, Wojtek Lesniak, Daniel P. Holt, Babak B. Azad, Robert F. Dannals, William Kem, Robert Freedman, Albert Gjedde

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)

Article Biochemistry & Molecular Biology

Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes

Kelly E. Dunn, Elise M. Weerts, Andrew S. Huhn, Jennifer R. Schroeder, David Andrew Tompkins, George E. Bigelow, Eric C. Strain

ADDICTION BIOLOGY (2020)

Article Psychology, Biological

Evaluation of Mifepristone Effects on Alcohol-Seeking and Self-Administration in Baboons

August F. Holtyn, Elise M. Weerts

EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2019)

Review Pharmacology & Pharmacy

Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence

Kelly E. Dunn, Andrew S. Huhn, Cecilia L. Bergeria, Cassandra D. Gipson, Elise M. Weerts

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)

Article Substance Abuse

Development of a novel alcohol and nicotine concurrent access (ANCA) self-administration procedure in baboons

August F. Holtyn, Catherine M. Davis, Elise M. Weerts

DRUG AND ALCOHOL DEPENDENCE (2020)

Article Substance Abuse

Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users

Tory R. Spindle, Edward J. Cone, Elia Goffi, Elise M. Weerts, John M. Mitchell, Ruth E. Winecker, George E. Bigelow, Ronald R. Flegel, Ryan Vandrey

DRUG AND ALCOHOL DEPENDENCE (2020)

Article Biochemistry & Molecular Biology

Sex differences in the acute effects of oral and vaporized cannabis among healthy adults

Dennis J. Sholler, Justin C. Strickland, Tory R. Spindle, Elise M. Weerts, Ryan Vandrey

Summary: Research comparing the acute effects of oral and vaporized cannabis in occasional users found that females exhibited stronger drug effects in some aspects, especially when controlling for body weight. Recommendations include starting with lower doses for females and being aware of potential acute anxiogenic reactions when using cannabinoids.

ADDICTION BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Brain imaging of cannabinoid type I (CB1) receptors in women with cannabis use disorder and male and female healthy controls

Tory R. Spindle, Hiroto Kuwabara, Alisha Eversole, Ayon Nandi, Ryan Vandrey, Denis G. Antoine, Annie Umbricht, Angela S. Guarda, Dean F. Wong, Elise M. Weerts

Summary: The study found that chronic cannabis use appears to lead to downregulation of CB1 receptors in women, similar to what has been observed in men previously. Female healthy controls had significantly higher CB1 receptor availability in brain regions compared to males. Gender differences play an important role in the effects of cannabis, progression to cannabis use disorder, and severity of withdrawal symptoms.

ADDICTION BIOLOGY (2021)

Article Psychology, Biological

A Double-Blind, Randomized, Placebo-Controlled, Pilot Clinical Trial Examining Buspirone as an Adjunctive Medication During Buprenorphine-Assisted Supervised Opioid Withdrawal

Cecilia L. Bergeria, Hongjun Tan, Denis Antoine, Elise M. Weerts, Andrew S. Huhn, J. Gregory Hobelmann, Kelly E. Dunn

Summary: Successful management of opioid withdrawal can improve treatment outcomes and reduce related morbidity and mortality. Buspirone, as an adjunct to opioid withdrawal, can alleviate withdrawal symptoms and positively impact sleep quality.

EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2023)

Article Pharmacology & Pharmacy

Evaluating Potential Anxiolytic Effects of Minor Cannabinoids and Terpenes After Acute and Chronic Oral Administration in Rats

Bryan W. Jenkins, Catherine F. Moore, Dan Covey, Jacob D. McDonald, Timothy W. Lefever, Marcel O. Bonn-Miller, Elise M. Weerts

Summary: This study evaluated the effects of minor cannabinoids and terpenes in tests sensitive to anxiety. The results suggest that some minor cannabinoids and terpenes may have anxiolytic properties.

CANNABIS AND CANNABINOID RESEARCH (2023)

Article Pharmacology & Pharmacy

Evaluation of the Modulatory Effects of Minor Cannabinoids and Terpenes on Delta-9-Tetrahydrocannabinol Discrimination in Rats

Catherine F. Moore, Julie Marusich, Mehdi Haghdoost, Timothy W. Lefever, Marcel O. Bonn-Miller, Elise M. Weerts

Summary: This study found that the minor cannabinoids and terpenes in cannabis have little effect on the interoceptive effects of D9-THC, suggesting that they are unlikely to lower the psychoactive effects of D9-THC in human users.

CANNABIS AND CANNABINOID RESEARCH (2023)

Article Pharmacology & Pharmacy

Pharmacokinetics of Oral Minor Cannabinoids in Blood and Brain

Catherine F. Moore, Elise M. Weerts, Justyna Kulpa, Daniela Schwotzer, Wendy Dye, Jacob Jantzi, Jacob D. McDonald, Timothy W. Lefever, Marcel O. Bonn-Miller

Summary: This study examined the pharmacokinetics of four minor cannabinoids (THCV, CBC, CBN, and D8-THC) after repeated oral dosing. The results showed detectable levels of these cannabinoids in plasma and their translocation to brain tissue. D8-THC exhibited the highest dose-normalized Cmax and AUClast. The concentration of THCV was lower on day 14, indicating potential adaptation and increased drug elimination. These findings are important for determining target dose ranges and dosing schedules in future studies evaluating the potential effects of these compounds.

CANNABIS AND CANNABINOID RESEARCH (2023)

Review Behavioral Sciences

Translational models of cannabinoid vapor exposure in laboratory animals

Catherine F. Moore, Jeffrey W. Stiltner, Catherine M. Davis, Elise M. Weerts

Summary: This review focuses on the emerging field of preclinical vapor models, specifically examining cannabinoid exposure. It summarizes vapor exposure parameters and other methodological details, discusses the pharmacological and behavioral effects of vaporized cannabinoids, and compares the behavioral effects of cannabinoid vapor administration with other routes of administration. This review serves as a guide for current and future research in vapor delivery methods in animals.

BEHAVIOURAL PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

A paradigm for examining stress effects on alcohol-motivated behaviors in participants with alcohol use disorder

Mary E. McCaul, Gary S. Wand, Elise M. Weerts, Xiaoqiang Xu

ADDICTION BIOLOGY (2018)

Article Substance Abuse

Baclofen and naltrexone effects on alcohol self-administration: Comparison of treatment initiated during abstinence or ongoing alcohol access in baboons

August F. Holtyn, Barbara J. Kaminski, Elise M. Weerts

DRUG AND ALCOHOL DEPENDENCE (2017)

暂无数据